BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Novartis AG (NVS) Drug Diovan Retains 69% of Prescriptions in U.S.


10/16/2012 8:14:03 AM

Novartis AG (NOVN) has held onto 69 percent of Diovan HCT prescriptions in the U.S. since since the heart drug, its best-selling product, lost patent protection in the country last month. The Swiss drugmaker retained U.S. market share by introducing its own branded copy through the Sandoz generics unit, Asthika Goonewardene, a London-based analyst for Bloomberg Industries, said in a note to clients today. U.S. prescriptions for Diovan HCT, a combination of Diovan and a diuretic, have dropped by 64 percent since Mylan Inc. (MYL) and Sandoz each introduced a copy of the pill more than three weeks ago, Goonewardene said. The Mylan product has taken 47 percent of the generic market, while the drug made by Sandoz holds 53 percent, he said. “Novartis is smart in that they’ve put their own version out,” Goonewardene said in a telephone interview today.

Read at Bloomberg

Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->